ANTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ANTA is a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has strong recent earnings growth, positive analyst ratings remain in place despite lower price targets, and the current price is near the lower end of the recent resistance range, giving a reasonable entry point for an investor who does not want to wait for a perfect pullback. Based on the data provided, I would rate it a buy.
The technical picture is mixed but acceptable for a long-term entry. Momentum is not strongly bullish yet: MACD histogram is slightly negative, RSI_6 at 63.56 is neutral-to-positive, and moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which shows the trend is still recovering rather than fully confirmed. Price at 9.74 is below R1 at 9.95 and above the pivot at 9.152, suggesting the stock is trading in the upper half of its recent range and not far from a breakout level. The stock trend model also suggests moderate upside over the next week and month. Overall, the technicals support a cautious buy rather than a chase.
["Q4 2025 revenue rose 149.78% YoY to 33,390,220.", "Q4 2025 net income rose 460.86% YoY to 9,341,494.", "Q4 2025 EPS increased 400% YoY to 0.35.", "Gross margin improved to 55.33%, up 9.74% YoY.", "B. Riley and Roth Capital both kept Buy ratings on the stock."]
["B. Riley cut its price target to $10 from $14.", "Roth Capital cut its price target to $12 from $18.50 and said Q1 guidance looks soft.", "No recent news in the past week, so there is no new catalyst from headlines.", "Technical trend is still not fully bullish, with bearish moving averages and slightly negative MACD.", "Hedge funds and insiders show neutral activity with no strong accumulation signal."]
The latest reported quarter was 2025/Q4, and it was very strong. Revenue increased to 33,390,220, up 149.78% year over year. Net income increased to 9,341,494, up 460.86% YoY. EPS increased to 0.35, up 400% YoY. Gross margin improved to 55.33%, up 9.74% YoY. This shows accelerating growth, rising profitability, and improved operating efficiency.
Recent analyst sentiment is still positive, but price targets have come down. On 2026-03-04, B. Riley lowered its target to $10 from $14 while keeping a Buy rating, citing strong Q4 growth. On 2026-03-03, Roth Capital lowered its target to $12 from $18.50 and also kept a Buy rating, noting soft Q1 guidance. Wall Street’s pros view is that growth and earnings are improving sharply, while the cons view is that expectations and near-term guidance are being trimmed. Overall, analysts remain constructive, but with less upside projected than before.
